Search research articles
Contact Us
Filters
Showing results (201-210 of 369) with videos related to
Page
of 37
Sort By:
Cancer Detection and Prevention
|
November 15, 2002
Genomics and proteomics: application of novel technology to early detection and prevention of cancer
Chad M Michener, Ali M Ardekani, Emmanuel F Petricoin, et al.
Seminars in Oncology
|
June 1, 1995
Paclitaxel, cisplatin, and cyclophosphamide in human ovarian cancer: molecular rationale and early clinical results
E Reed, E C Kohn, G Sarosy, et al.
Cancer Science
|
September 6, 2007
Targeted optical fluorescence imaging of human ovarian adenocarcinoma using a galactosyl serum albumin-conjugated fluorophore
Andrew J Gunn, Yukihiro Hama, Yoshinori Koyama, et al.
Gastrointestinal Endoscopy
|
August 18, 2009
Rectal fistulae resulting from treatment with sorafenib and bevacizumab
Erik C von Rosenvinge, Lakshmi D Gopal, Theo Heller, et al.
Aesthetic Surgery Journal
|
March 27, 2014
Hyaluronic acid gel distribution pattern in periocular area with high-resolution ultrasound imaging
Alice S Goh, Jocelyne C Kohn, Daniel B Rootman, et al.
Carcinogenesis
|
September 23, 1998
Differences in kinetics of induction and reversibility of TCDD-induced changes in cell proliferation and CYP1A1 expression in female Sprague-Dawley rat liver
N J Walker, B D Miller, M C Kohn, et al.
Investigative Ophthalmology & Visual Science
|
September 29, 2004
CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy
Alan J Franklin, Tom L Jetton, C Lynn Kuchemann, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine
|
October 4, 2015
Can Sonography Distinguish a Supraorbital Notch From a Foramen?
Ravi K Garg, Kenneth S Lee, Sarah C Kohn, et al.
Expert Opinion on Investigational Drugs
|
February 23, 2016
Cediranib, a pan-VEGFR inhibitor, and olaparib, a PARP inhibitor, in combination therapy for high grade serous ovarian cancer
S Percy Ivy, Joyce F Liu, Jung-Min Lee, et al.
Journal of Cellular Physiology
|
August 28, 2003
Regulation of the pro-angiogenic microenvironment by carboxyamido-triazole
Vyta Kulpa Oliver, Angela M Patton, Sudhen Desai, et al.
Page
of 37
Search research articles
Search
Showing results (201-210 of 369) with videos related to
Sort By:
Page
of 37
Cancer Detection and Prevention
|
November 15, 2002
Genomics and proteomics: application of novel technology to early detection and prevention of cancer
Chad M Michener, Ali M Ardekani, Emmanuel F Petricoin, et al.
Seminars in Oncology
|
June 1, 1995
Paclitaxel, cisplatin, and cyclophosphamide in human ovarian cancer: molecular rationale and early clinical results
E Reed, E C Kohn, G Sarosy, et al.
Cancer Science
|
September 6, 2007
Targeted optical fluorescence imaging of human ovarian adenocarcinoma using a galactosyl serum albumin-conjugated fluorophore
Andrew J Gunn, Yukihiro Hama, Yoshinori Koyama, et al.
Gastrointestinal Endoscopy
|
August 18, 2009
Rectal fistulae resulting from treatment with sorafenib and bevacizumab
Erik C von Rosenvinge, Lakshmi D Gopal, Theo Heller, et al.
Aesthetic Surgery Journal
|
March 27, 2014
Hyaluronic acid gel distribution pattern in periocular area with high-resolution ultrasound imaging
Alice S Goh, Jocelyne C Kohn, Daniel B Rootman, et al.
Carcinogenesis
|
September 23, 1998
Differences in kinetics of induction and reversibility of TCDD-induced changes in cell proliferation and CYP1A1 expression in female Sprague-Dawley rat liver
N J Walker, B D Miller, M C Kohn, et al.
Investigative Ophthalmology & Visual Science
|
September 29, 2004
CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy
Alan J Franklin, Tom L Jetton, C Lynn Kuchemann, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine
|
October 4, 2015
Can Sonography Distinguish a Supraorbital Notch From a Foramen?
Ravi K Garg, Kenneth S Lee, Sarah C Kohn, et al.
Expert Opinion on Investigational Drugs
|
February 23, 2016
Cediranib, a pan-VEGFR inhibitor, and olaparib, a PARP inhibitor, in combination therapy for high grade serous ovarian cancer
S Percy Ivy, Joyce F Liu, Jung-Min Lee, et al.
Journal of Cellular Physiology
|
August 28, 2003
Regulation of the pro-angiogenic microenvironment by carboxyamido-triazole
Vyta Kulpa Oliver, Angela M Patton, Sudhen Desai, et al.
Page
of 37